These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Medical parathyroidectomy. Its efficacy in treatment of lower maxillary brown tumor]. Graciela Garcia M; Leanza H; Najun Zarazga C; Barreneche M Medicina (B Aires); 1996; 56(1):59-62. PubMed ID: 8734935 [TBL] [Abstract][Full Text] [Related]
3. Management of disturbed calcium metabolism in uraemic patients: 2. Indications for parathyroidectomy. Schömig M; Ritz E Nephrol Dial Transplant; 2000; 15 Suppl 5():25-9. PubMed ID: 11073271 [No Abstract] [Full Text] [Related]
4. A study on pruritus after parathyroidectomy for secondary hyperparathyroidism. Chou FF; Ho JC; Huang SC; Sheen-Chen SM J Am Coll Surg; 2000 Jan; 190(1):65-70. PubMed ID: 10625234 [TBL] [Abstract][Full Text] [Related]
5. [Secondary hyperparathyroidism manifesting as cutaneous gangrene in a patient on hemodialysis (uremic gangrene syndrome)]. Török L; Középessy L; Suhajda K Hautarzt; 1990 Dec; 41(12):689-91. PubMed ID: 2089028 [TBL] [Abstract][Full Text] [Related]
6. [Cutaneous gangrene secondary to nephrogenic hyperparathyroidism]. Török L; Középessy L; Suhajda K Orv Hetil; 1991 Feb; 132(5):259-60, 263-4. PubMed ID: 1996211 [TBL] [Abstract][Full Text] [Related]
7. Uraemic gangrene syndrome. Török L; Középessy L Acta Derm Venereol; 1991; 71(5):455-7. PubMed ID: 1684482 [TBL] [Abstract][Full Text] [Related]
8. The uremic gangrene syndrome: improved healing in spontaneously forming wounds following subtotal parathyroidectomy. Kane WJ; Petty PM; Sterioff S; McCarthy JT; Crotty TB Plast Reconstr Surg; 1996 Sep; 98(4):671-8. PubMed ID: 8773689 [TBL] [Abstract][Full Text] [Related]
9. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797 [TBL] [Abstract][Full Text] [Related]
10. Predicting postoperative total calcium requirements after parathyroidectomy in secondary hyperparathyroidism. Kang BH; Hwang SY; Kim JY; Hong YA; Jung MY; Lee EA; Lee JE; Lee JB; Ko GJ; Pyo HJ; Kwon YJ Korean J Intern Med; 2015 Nov; 30(6):856-64. PubMed ID: 26552461 [TBL] [Abstract][Full Text] [Related]
11. [Re-operation treatment in uremic patients complicated with persistent secondary hyperparathyroidism after parathyroidectomy with autotransplantation]. Bo SJ; Xu XF; Qiu CY; Wang TT; Ning YD; Li HY Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jan; 32(2):142-147. PubMed ID: 29757564 [No Abstract] [Full Text] [Related]
13. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016 [TBL] [Abstract][Full Text] [Related]
14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
15. The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats. Cozzolino M; Dusso AS; Liapis H; Finch J; Lu Y; Burke SK; Slatopolsky E J Am Soc Nephrol; 2002 Sep; 13(9):2299-308. PubMed ID: 12191974 [TBL] [Abstract][Full Text] [Related]